476 results on '"Schwartz, Cindy L."'
Search Results
2. Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).
3. A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma
4. Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials
5. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group
6. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia
7. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children
8. Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031
9. The Thyroid Gland
10. Facilitating Assessment of Late Effects by Organ System
11. Algorithms of Late Effects by Disease
12. Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
13. Pediatric Hodgkin Lymphoma
14. Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children’s Oncology Group protocol AHOD0031
15. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
16. Next Steps: Survivor Healthcare Passport — A Novel Form of Survivorship Care Plan in the Pediatric Population
17. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
18. The Thyroid Gland
19. Facilitating Assessment of Late Effects by Organ System
20. Algorithms of Late Effects by Disease
21. Patterns of Relapse From a Phase 3 Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group
22. Radiotherapy Quality Assurance Report From Children's Oncology Group AHOD0031
23. Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease
24. Evaluating CHIPS in Pediatric High Risk Hodgkin Lymphoma Treated on AHOD1331
25. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031
26. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Childrenʼs Oncology Group (COG AHOD0031) comparative analysis
27. Overview
28. Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031.
29. Outcomes of patients with bilateral retinoblastoma: A report from the RIVERBOAT Consortium.
30. Outcomes of patients with unilateral retinoblastoma: A report from the RIVERBOAT Consortium.
31. Mental distress and health care use among survivors of adolescent and young adult cancer: A cross‐sectional analysis of the National Health Interview Survey
32. Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group
33. Cancers in Childhood
34. Osteosarcoma
35. ACR Appropriateness Criteria® on Hodgkin's Lymphoma-Unfavorable Clinical Stage I and II
36. Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
37. Pediatric Hodgkin Lymphoma
38. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
39. Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group
40. A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425
41. A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Childrenʼs Oncology Group study
42. Ifosfamide and Vinorelbine Is an Effective Reinduction Regimen in Children With Refractory/Relapsed Hodgkin Lymphoma, AHOD00P1: A Childrenʼs Oncology Group Report
43. Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup from COG AHOD0031
44. ACR Appropriateness Criteria® Pediatric Hodgkin Lymphoma
45. Analysis of Serum Insulin Growth Factor-1 Concentrations in Localized Osteosarcoma: A Childrenʼs Oncology Group Study
46. Special issues in pediatric Hodgkinʼs disease
47. Pediatric classical Hodgkin lymphoma
48. Additional file 1 of Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
49. Chronic health conditions in adult survivors of childhood cancer
50. Survival Differs by Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.